Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat

Free Radical Research

Volumn 44, Issue 8, 2010, Pages 854-863

  Zúñiga, Jessica ^a   Venegas, Francisca ^a   Villarreal, Marcela ^a   Núñez, Daniel ^a   Chandía, Marlene ^a   Valenzuela, Rodrigo ^b   Tapia, Gladys ^a   Varela, Patricia ^a   Videla, Luis A ^a   Fernández, Virginia ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Ischemia reperfusion injury; liver preconditioning; n 3 polyunsaturated fatty acid; NF B activation; oxidative stress; pro infl ammatory cytokines

Indexed keywords

8 ISOPROSTANE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DOCOSAHEXAENOIC ACID; FISH OIL; GLUTATHIONE; GLUTATHIONE DISULFIDE; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID PLUS DOCOSAHEXAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DNA BINDING; HOMEOSTASIS; IN VIVO STUDY; LIPID COMPOSITION; LIVER HISTOLOGY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; SHAM PROCEDURE;

ANIMALS; CYTOKINES; DIETARY SUPPLEMENTS; DNA; FATTY ACIDS, OMEGA-3; LIVER; MALE; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

RATTUS;

EID: 77956363035     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2010.485995     Document Type: Article

References (41)

1. De Rougemont O, Lehmann K, Clavien PA. Preconditioning, Organ preservation, And postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl 2009; 15: 1172-1182.
2. Cutr í n JC, Boveris A, Zingaro B, Corvetti G, Poli G. In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment. Hepatology 2000;31:622-632.
3. Massip-Salcedo M, Rosello-Catafau J, Prieto J, Avila MA, Peralta C. The response of the hepatocyte to ischemia. Liver Int 2007;27:6-16.
4. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996;23:506-514.
5. Casillas-Ramirez A, Mosbah IB, Ramalho F, Rosello-Catafau J, Peralta C. Past and future approaches to ischemia-reper-fusion lesion associated with liver transplantation. Life Sci 2006;79:1881-1894.
6. Fetterman JR, Jr, Zdanowicz MM. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health-Syst Pharm 2009;66:1169-1179.
7. Demoz A, Willumsen N, Berge RK. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids 1992;27:968-971.
8. Obata T, Nagakura T, Masaki T, Maekawa K, Yamashita K. Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy 1999;29:1129-1135.
9. Calder PC. n-3 Polyunsaturated fatty acids, Inflammation, And inflammatory diseases. Am J Clin Nutr 2006;83:1505S-1519S.
10. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual antiinflammatory and proresolution lipid mediators. Nature Rev Immunol 2008;8:349-361.
11. De Roos B, Mavrommatis Y, Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to Inflammation and coronary heart disease. Br J Pharmacol 2009;158:413-428.
12. Calder PC. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 2009;91:791-795.
13. Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in Inflammation control. J Endocrinol 2001;169:453-459. (Pubitemid 32536978)
14. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced Inflammation responses in HK-2 cells: Evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005;67:867-874.
15. Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008;19:242-247.
16. Fern á ndez V, Castillo I, Tapia G, Romanque P, Uribe-Echevarr í a S, Uribe M, Cartier-Ugarte D, Santander G, Vial MT, Videla LA. Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology 2007;45:170-177.
17. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37: 911-917.
18. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with fluoride-methanol. J Lipid Res 1964;5: 600-608.
19. Deryckere F, Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 1994;16:405.
20. Tapia G, Fern á ndez V, Varela P, Cornejo P, Guerrero J, Videla LA. Thyroid hormone-induced oxidative stress triggers nuclear factor-κ B and cytokine gene expression in rat liver. Free Radic Biol Med 2003;35:257-265.
21. Fern á ndez V, Tapia G, Varela P, Gaete L, Vera G, Mora C, Vial MT, Videla LA. Causal role of oxidative stress in liver preconditioning by thyroid hormone in rats. Free Radic Biol Med 2008;44:1724-1731.
22. Fern á ndez V, Tapia G, Varela P, Cornejo P, Videla LA. Upregulation of liver inducible nitric oxide synthase following thyroid hormone preconditioning: suppression by N-acetyl-cysteine. Biol Res 2009;42:487-495.
23. Giakoustidis DE, Iliadis S, Tsantilas D, Papageorgiou G, Kontos N, Kostopoulou E, Botsoglou NA, Gerasimidis T, Dimitriadou A. Blockade of Kupffer cells by gadolinium chloride reduces lipid peroxidation and protects the liver from ischemia/reperfusion injury. Hepatogastroenterology 2003;50:1587-1592.
24. 3 against hepatic ischemia/reperfusion injury. Surg Today 2006;36:450-456.
25. Parola M, Robimo G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001;35:297-306.
26. Tsukamoto H, Lin M. The role of Kupffer cells in liver injury. In: Wisse E, Knook DL, Balabaud C, editors. Cells of the hepatic sinusoid. vol.6. Leiden, The Netherlands: The Kupffer Cell Foundation; 1997. p 244-250.
27. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006;26:1175-1186.
28. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerani A, Palladino MA, O ' Connor J V. Tumor necrosis factor (cathectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 1986;163:1433-1450.
29. Iwakasi W, Kume M, Kudo K, Uchinami H, Kikuchi I, Nakagawa Y, Yoshioka M, Yamamoto Y. Changes in the fatty acid composition of the liver with the administration of n-3 polyunsaturated fatty acids and the effects on warm ischemia/reperfusion injury in the rat liver. Shock. 2010;33:306-314.
30. Zhong Z, Thurman RG. A fish oil diet minimizes hepatic reperfusion injury in the low-flow, reflow liver perfusion model. Hepatology 1995;22:929-935.
31. El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien PA. Prevention of reperfusion injury and microcircu-latory failure in macrosteatotic Mouse liver by omega-3 fatty acids. Hepatology 2007;45:855-863.
32. El-Badry AM, Graf R, Clavien PA. Omega 3-omega 6: what is right for the liver? J Hepatol 2007;47:718-725.
33. Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic necrosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006;23:1143-1151.
34. Elizondo A, Araya J, Rodrigo R, Poniachik J, Csendes A, Maluenda F, D í az JC, Signorini C, Sgherri C, Comporti M, Videla LA. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity 2007;15:24-31.
35. Pettinelli P, del Pozo T, Araya J, Rodrigo R, Araya AV, Smok G, Csendes A, Gutierrez L, Rojas J, Korn O, Maluenda F, D í az JC, Rencoret G, Braghetto I, Castillo J, Poniachik J, Videla LA. Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim Biophys Acta Mol Basis Dis 2009;1792: 1080-1086.
36. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Ann Rev Nutr 1985;5:365-390.
37. Lands WE, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, Schmeisser D, Burns JH. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1992;1180:147-162.
38. Videla LA. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol 2009;1: 73-79.
39. Gloire G, Legrand-Poels S, Piette J. NF-κ Bactivation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006;72:1493-1505.
40. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006;38:769-789.
41. Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN, Sasi S, Dalton TP, Anderson ME, Chan JY, Morrow JD. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 2007;282:2529-2537.